Immune Regulation and Evasion of Mammalian Host Cell Immunity During Viral Infection

[1]  P. Lampertico,et al.  IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection , 2012, The Journal of Immunology.

[2]  Hong Jiang,et al.  Human leukocyte antigen E in human cytomegalovirus infection: friend or foe? , 2012, Acta biochimica et biophysica Sinica.

[3]  J. Neefjes,et al.  Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.

[4]  A. Weinberg,et al.  Dynamics of Regulatory T-Cells during Pregnancy: Effect of HIV Infection and Correlations with Other Immune Parameters , 2011, PloS one.

[5]  Andreas Achleitner,et al.  T-regulatory cells infected with feline immunodeficiency virus up-regulate programmed death-1 (PD-1). , 2011, Veterinary immunology and immunopathology.

[6]  C. Basler,et al.  Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells , 2011, Immunology and cell biology.

[7]  Z. Bánki,et al.  Emerging role for complement in HIV infection. , 2011, Current opinion in HIV and AIDS.

[8]  J. Koch,et al.  Structural and functional analysis of the TAP-inhibiting UL49.5 proteins of varicelloviruses. , 2011, Molecular immunology.

[9]  I. Frazer,et al.  NKT Cells Inhibit Antigen-Specific Effector CD8 T Cell Induction to Skin Viral Proteins , 2011, The Journal of Immunology.

[10]  Sun Park,et al.  CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model. , 2011, Cytotherapy.

[11]  Sujay K. Singh,et al.  “Toll” Extending Its Gate from Drosophila Development to T Cell Response: Implication in Innate Immunity, Adaptive Immunity and Immunotherapy , 2011 .

[12]  Tracey M. Filzen,et al.  HIV-1 Nef Disrupts Intracellular Trafficking of Major Histocompatibility Complex Class I, CD4, CD8, and CD28 by Distinct Pathways That Share Common Elements , 2011, Journal of Virology.

[13]  T. Geiser,et al.  Monocyte differentiation toward regulatory dendritic cells is not affected by respiratory syncytial virus-induced inflammatory mediators. , 2011, American journal of respiratory cell and molecular biology.

[14]  J. Rushton,et al.  Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection. , 2011, Virology.

[15]  R. Ferris,et al.  The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. , 2011, Virology.

[16]  S. Miller,et al.  CNS Expression of B7-H1 Regulates Pro-Inflammatory Cytokine Production and Alters Severity of Theiler's Virus-Induced Demyelinating Disease , 2011, PloS one.

[17]  Kerstin Radtke,et al.  Alternative pathways for MHC class I presentation: a new function for autophagy , 2011, Cellular and Molecular Life Sciences.

[18]  J. Prieto,et al.  Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. , 2011, Journal of hepatology.

[19]  M. Ressing,et al.  Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls , 2011, Immunology and cell biology.

[20]  F. Neipel,et al.  Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 3 Inhibits Gamma Interferon and Major Histocompatibility Complex Class II Expression , 2011, Journal of Virology.

[21]  K. Conzelmann,et al.  The Measles Virus V Protein Binds to p65 (RelA) To Suppress NF-κB Activity , 2011, Journal of Virology.

[22]  J. Stindt,et al.  Human Cytomegalovirus Disrupts the Major Histocompatibility Complex Class I Peptide-Loading Complex and Inhibits Tapasin Gene Transcription , 2011, Journal of Virology.

[23]  N. Sullivan,et al.  Ebolavirus Proteins Suppress the Effects of Small Interfering RNA by Direct Interaction with the Mammalian RNA Interference Pathway , 2011, Journal of Virology.

[24]  R. Lin,et al.  Kaposi Sarcoma-associated Herpesvirus Degrades Cellular Toll-Interleukin-1 Receptor Domain-containing Adaptor-inducing β-Interferon (TRIF)* , 2011, The Journal of Biological Chemistry.

[25]  D. Brooks,et al.  The role of IL-10 in regulating immunity to persistent viral infections. , 2011, Current Topics in Microbiology and Immunology.

[26]  A. Møller,et al.  Discovery of a Viral NLR Homolog that Inhibits the Inflammasome , 2011 .

[27]  B. Anukumar,et al.  Immune regulation in Chandipura virus infection: characterization of CD4+ T regulatory cells from infected mice , 2011, Virology Journal.

[28]  B. Ni,et al.  Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients , 2011, BMC Immunology.

[29]  M. Gale,et al.  Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity , 2011, Gastroenterology research and practice.

[30]  S. Lemon,et al.  Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses. , 2010, Seminars in liver disease.

[31]  H. Gendelman,et al.  Functional Proteomic Analysis for Regulatory T Cell Surveillance of the HIV-1-Infected Macrophage , 2010, Journal of proteome research.

[32]  J. Mullins,et al.  Dendritic Cells Reveal a Broad Range of MHC Class I Epitopes for HIV-1 in Persons with Suppressed Viral Load on Antiretroviral Therapy , 2010, PloS one.

[33]  C. Münz,et al.  MHC presentation via autophagy and how viruses escape from it , 2010, Seminars in Immunopathology.

[34]  S. Kōzuma,et al.  CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV , 2010, Journal of Virology.

[35]  H. Ploegh,et al.  The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation , 2010, The Journal of experimental medicine.

[36]  C. Horvath,et al.  Dissociation of Paramyxovirus Interferon Evasion Activities: Universal and Virus-Specific Requirements for Conserved V Protein Amino Acids in MDA5 Interference , 2010, Journal of Virology.

[37]  O. Martínez-Maza,et al.  HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma , 2010, Immunologic research.

[38]  O. Laeyendecker,et al.  C-Reactive Protein Levels Increase During HIV-1 Disease Progression in Rakai, Uganda, Despite the Absence of Microbial Translocation , 2010, Journal of acquired immune deficiency syndromes.

[39]  J. Knutson,et al.  HIV-1 Nef Binds a Subpopulation of MHC-I throughout Its Trafficking Itinerary and Down-regulates MHC-I by Perturbing Both Anterograde and Retrograde Trafficking* , 2010, The Journal of Biological Chemistry.

[40]  S. Sehrawat,et al.  Immunity and immunopathology to viruses: what decides the outcome? , 2010, Nature Reviews Immunology.

[41]  J. Melero,et al.  TLR4-independent upregulation of activation markers in mouse B lymphocytes infected by HRSV. , 2010, Molecular immunology.

[42]  R. D. de Knegt,et al.  Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. , 2010, Journal of hepatology.

[43]  S. Günther,et al.  T Cell-Dependence of Lassa Fever Pathogenesis , 2010, PLoS pathogens.

[44]  S. Amigorena,et al.  Intracellular mechanisms of antigen cross presentation in dendritic cells. , 2010, Current opinion in immunology.

[45]  S. Diebold.  Innate recognition of viruses. , 2010, Immunology letters.

[46]  N. Shastri,et al.  Cross‐presentation of peptides from intracellular pathogens by MHC class I molecules , 2010, Annals of the New York Academy of Sciences.

[47]  K. Kodys,et al.  Impaired expression and function of toll‐like receptor 7 in hepatitis C virus infection in human hepatoma cells , 2010, Hepatology.

[48]  H. Favoreel,et al.  Pseudorabies virus US3- and UL49.5-dependent and -independent downregulation of MHC I cell surface expression in different cell types. , 2009, Virology.

[49]  K. Rock,et al.  Proteases in MHC Class I Presentation and Cross-Presentation , 2009, The Journal of Immunology.

[50]  M. Desjardins,et al.  Nuclear membrane-derived autophagy, a novel process that participates in the presentation of endogenous viral antigens during HSV-1 infection , 2009, Autophagy.

[51]  A. Steinkasserer,et al.  Herpes simplex virus type I infection of mature dendritic cells leads to reduced LMP7-mRNA-expression levels. , 2009, Immunobiology.

[52]  M. Piatak,et al.  Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8(+) T cells independent of IFN-gamma and CD107a responses. , 2009, Virology.

[53]  Sebastian Reuter,et al.  Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells. , 2009, Blood.

[54]  R. Katoh,et al.  Enterovirus Infection, CXC Chemokine Ligand 10 (CXCL10), and CXCR3 Circuit , 2009, Diabetes.

[55]  Justin M. Richner,et al.  Host Shutoff Is a Conserved Phenotype of Gammaherpesvirus Infection and Is Orchestrated Exclusively from the Cytoplasm , 2009, Journal of Virology.

[56]  M. Bouvier,et al.  MHC class I antigen presentation: learning from viral evasion strategies , 2009, Nature Reviews Immunology.

[57]  E. Sousa,et al.  Innate recognition of viruses , 2009 .

[58]  J. Melero,et al.  Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes , 2009, Immunology and cell biology.

[59]  R. Lippé,et al.  Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection , 2009, Nature Immunology.

[60]  H. Gendelman,et al.  Neuromodulatory Activities of CD4+CD25+ Regulatory T Cells in a Murine Model of HIV-1-Associated Neurodegeneration1 , 2009, The Journal of Immunology.

[61]  R. Friedline,et al.  CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance , 2009, The Journal of experimental medicine.

[62]  A. Boonstra,et al.  Modulation of dendritic cell function by persistent viruses , 2009, Journal of leukocyte biology.

[63]  M. Ressing,et al.  The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation , 2009, PLoS pathogens.

[64]  D. Tortorella,et al.  Human Cytomegalovirus-Encoded Immune Modulators Partner To Downregulate Major Histocompatibility Complex Class I Molecules , 2008, Journal of Virology.

[65]  I. Ernberg,et al.  Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. , 2008, The American journal of pathology.

[66]  T. Kanto.  Virus associated innate immunity in liver. , 2008, Frontiers in bioscience : a journal and virtual library.

[67]  R. Tampé,et al.  Varicellovirus UL49.5 Proteins Differentially Affect the Function of the Transporter Associated with Antigen Processing, TAP , 2008, PLoS pathogens.

[68]  B. Clotet,et al.  A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals. , 2008, Virus research.

[69]  A. Sahu,et al.  Viral mimicry of the complement system , 2003, Journal of Biosciences.

[70]  Yaling Zhou.  Regulatory T cells and viral infections. , 2008, Frontiers in bioscience : a journal and virtual library.

[71]  S. Grabbe,et al.  Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cells. , 2007, Blood.

[72]  W. Yokoyama,et al.  Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. , 2007, Cell host & microbe.

[73]  J. Casanova,et al.  Human Toll‐like receptor‐dependent induction of interferons in protective immunity to viruses , 2007, Immunological reviews.

[74]  M. Ressing,et al.  A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates , 2007, The Journal of experimental medicine.

[75]  A. Eisfeld,et al.  Downregulation of Class I Major Histocompatibility Complex Surface Expression by Varicella-Zoster Virus Involves Open Reading Frame 66 Protein Kinase-Dependent and -Independent Mechanisms , 2007, Journal of Virology.

[76]  S. Ferrone,et al.  Association of immunoescape mechanisms with Epstein‐Barr virus infection in nasopharyngeal carcinoma , 2007, International journal of cancer.

[77]  P. Moore,et al.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mimics Epstein-Barr Virus EBNA1 Immune Evasion through Central Repeat Domain Effects on Protein Processing , 2007, Journal of Virology.

[78]  D. Meyerholz,et al.  Neonatal ovine pulmonary dendritic cells support bovine respiratory syncytial virus replication with enhanced interleukin (IL)-4 And IL-10 gene transcripts. , 2007, Viral immunology.

[79]  M. Gale,et al.  Functional and Therapeutic Analysis of Hepatitis C Virus NS3·4A Protease Control of Antiviral Immune Defense* , 2007, Journal of Biological Chemistry.

[80]  P. Vandenabeele,et al.  RIP1, a kinase on the crossroads of a cell's decision to live or die , 2007, Cell Death and Differentiation.

[81]  Bjoern Peters,et al.  The CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus Involves the L Antigen: Uncovering New Tricks for an Old Virus , 2007, Journal of Virology.

[82]  E. Wiertz,et al.  In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus. , 2007, Molecular immunology.

[83]  G. Bornkamm,et al.  c-MYC impairs immunogenicity of human B cells. , 2007, Advances in cancer research.

[84]  Adeeba Kamarulzaman,et al.  AIDS Res Hum Retroviruses , 2006 .

[85]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[86]  B. Rouse,et al.  Regulatory T cells in virus infections , 2006, Immunological reviews.

[87]  P. Codogno,et al.  Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. , 2006, The Journal of clinical investigation.

[88]  D. Blackbourn,et al.  HIV Tat-mediated transcriptional regulation of proteasome protein cleavage specificity. , 2006, The Biochemical journal.

[89]  Youngkyun Kim,et al.  A Short Isoform of Human Cytomegalovirus US3 Functions as a Dominant Negative Inhibitor of the Full-Length Form , 2006, Journal of Virology.

[90]  S. Mayor,et al.  The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs , 2006, The Journal of Immunology.

[91]  B. Rouse,et al.  Qa-1b and CD94-NKG2a Interaction Regulate Cytolytic Activity of Herpes Simplex Virus-Specific Memory CD8+ T Cells in the Latently Infected Trigeminal Ganglia1 , 2006, The Journal of Immunology.

[92]  A. McMichael,et al.  HIV‐1 down‐regulates the expression of CD1d via Nef , 2006, European journal of immunology.

[93]  Allison L. Zajac,et al.  Genome-Wide Analysis Reveals a Highly Diverse CD8 T Cell Response to Murine Cytomegalovirus , 2006 .

[94]  R. Tampé,et al.  The Intracellular Antigen Transport Machinery TAP in Adaptive Immunity and Virus Escape Mechanisms , 2005, Journal of bioenergetics and biomembranes.

[95]  E. Harris,et al.  Critical Roles for Both STAT1-Dependent and STAT1-Independent Pathways in the Control of Primary Dengue Virus Infection in Mice1 , 2005, The Journal of Immunology.

[96]  A. Bowie,et al.  Vaccinia Virus Protein A52R Activates p38 Mitogen-activated Protein Kinase and Potentiates Lipopolysaccharide-induced Interleukin-10* , 2005, Journal of Biological Chemistry.

[97]  M. Gale,et al.  Evasion of intracellular host defence by hepatitis C virus , 2005, Nature.

[98]  S. Chattopadhyay,et al.  Regulatory T cells and tumor immunity , 2005, Cancer Immunology, Immunotherapy.

[99]  R. Tampé,et al.  Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[100]  R. Flavell,et al.  Toll-like receptor 3 promotes cross-priming to virus-infected cells , 2005, Nature.

[101]  Stanley M Lemon,et al.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[102]  J. McCluskey,et al.  TAP genes and immunity. , 2004, Current opinion in immunology.

[103]  Y. Hiasa,et al.  Major histocompatibility complex class‐I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation , 2004, Journal of medical virology.

[104]  G. Ruthel,et al.  Ebola and Marburg virus-like particles activate human myeloid dendritic cells. , 2004, Virology.

[105]  M. Groettrup,et al.  A Cytomegalovirus Inhibitor of Gamma Interferon Signaling Controls Immunoproteasome Induction , 2004, Journal of Virology.

[106]  D. Griffin.  Arboviruses and the central nervous system , 1995, Springer Seminars in Immunopathology.

[107]  A. Hilgendorf,et al.  Immune evasion by adenovirus E3 proteins: exploitation of intracellular trafficking pathways. , 2004, Current topics in microbiology and immunology.

[108]  E. Ortega,et al.  Antigen presentation by a macrophage-like cell line persistently infected with respiratory syncytial virus. , 2004, Virus research.

[109]  M. Mohamadzadeh,et al.  Ebola virus-like particles protect from lethal Ebola virus infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[110]  R. Ellison.  Immune Evasion , 2003, Science's STKE.

[111]  F. Hufert,et al.  Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape , 2003, European journal of immunology.

[112]  S. Sakaguchi.  Control of Immune Responses by Naturally Arising CD4+ Regulatory T Cells That Express Toll-like Receptors , 2003, The Journal of experimental medicine.

[113]  H. Virgin,et al.  Virus subversion of the MHC class I peptide-loading complex. , 2003, Immunity.

[114]  M. del-Val,et al.  Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes. , 2002, Molecular immunology.

[115]  R. Zinkernagel.  On cross‐priming of MHC class I‐specific CTL: rule or exception? , 2002, European journal of immunology.

[116]  V. Levitsky,et al.  Manipulation of immune responses by Epstein-Barr virus. , 2002, Virus research.

[117]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[118]  R. Means,et al.  Multiple endocytic trafficking pathways of MHC class I molecules induced by a Herpesvirus protein , 2002, The EMBO journal.

[119]  J. Kim,et al.  HIV-1 viral protein R compromises cellular immune function in vivo. , 2002, International immunology.

[120]  M. Masucci,et al.  Avoiding proteasomal processing: the case of EBNA1. , 2002, Current topics in microbiology and immunology.

[121]  E. Shevach.  CD4CD25 SUPPRESSOR T CELLS: MORE QUESTIONS THAN ANSWERS , 2002 .

[122]  E. Breij,et al.  Interactions between major histocompatibility complex class II surface expression and HIV: implications for pathogenesis , 2001, European journal of clinical investigation.

[123]  M. Ressing,et al.  The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1. , 2001, The Journal of general virology.

[124]  J. Lifson,et al.  Differential Incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and Major Histocompatibility Complex Class I and II Molecules into Human Immunodeficiency Virus Type 1 Virions and Microvesicles: Implications for Viral Pathogenesis and Immune Regulation , 2001, Journal of Virology.

[125]  Kamp,et al.  Mechanisms of HIV‐1 to escape from the host immune surveillance , 2000, European journal of clinical investigation.

[126]  D. Trono,et al.  HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes , 2000, Nature Cell Biology.

[127]  J. Fazakerley,et al.  Phenotypic characterisation and infection of ovine microglial cells with Maedi-Visna virus. , 2000, Journal of neurovirology.

[128]  J. Cox.  Evaluation of natural killer cell activity. , 2000, Methods in molecular medicine.

[129]  A. Goldberg,et al.  Proteolysis and class I major histocompatibility complex antigen presentation , 1999, Immunological reviews.

[130]  C. Karp.  Measles: immunosuppression, interleukin‐12. and complement receptors , 1999, Immunological reviews.

[131]  U. Koszinowski,et al.  A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation , 1999, The EMBO journal.

[132]  F. Sobrino,et al.  Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. , 1998, The Journal of general virology.

[133]  C. Ware,et al.  The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis , 1997, Journal of virology.

[134]  K. McCullough,et al.  Rinderpest virus isolates of different virulence vary in their capacity to infect bovine monocytes and macrophages. , 1997, The Journal of general virology.

[135]  B. Pedersen,et al.  Clinical Progression of HIV Infection: Role of NK Cells , 1997, Scandinavian journal of immunology.

[136]  R. Bolea,et al.  Effect of in vitro maedi-visna virus infection on adherence and phagocytosis of staphylococci by ovine cells. , 1997, Veterinary microbiology.

[137]  P. Cresswell,et al.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[138]  U. Koszinowski,et al.  A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.

[139]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[140]  L. Harbige,et al.  Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection , 1997, Journal of Neuroimmunology.

[141]  G. Allan,et al.  Effect of porcine circovirus infection on porcine alveolar macrophage function. , 1996, Veterinary Immunology and Immunopathology.

[142]  Z. Xiang,et al.  Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[143]  P. A. Peterson,et al.  A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.

[144]  J. Yewdell,et al.  Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.

[145]  D. Griffin,et al.  Apoptosis as a cause of death in measles virus-infected cells , 1995, Journal of virology.

[146]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[147]  D. Pfaff,et al.  Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. , 1994, Gene therapy.

[148]  M. Horwitz,et al.  Characterization of transgenic mice containing adenovirus early region 3 genomic DNA , 1994, Journal of virology.

[149]  C. Parker,et al.  Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis. , 1994, AIDS research and human retroviruses.

[150]  G. Nemerow,et al.  Epstein-Barr virus regulates activation and processing of the third component of complement , 1988, The Journal of experimental medicine.

[151]  P. A. Peterson,et al.  Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[152]  G. Rice,et al.  Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. , 1986, The Journal of infectious diseases.

[153]  R. Eisenberg,et al.  Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells , 1984, Nature.

[154]  M. Epstein,et al.  The Epstein-Barr Virus , 1979, Springer Berlin Heidelberg.

[155]  M. Bevan.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay , 1976, The Journal of experimental medicine.